GH1 and acromegaly: The recommended medical therapies for acromegaly according to the guidelines of the Endocrine Society (ENDO) are pegvisomant (GH-receptor blocking agents) and somatostatin receptor ligands (SRLs) [41], which are dependent on the blocking GH from acting.